Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma

Clinical trial NCT05853965 · RECRUITING

Trial details

NCT number: NCT05853965
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Multiple Myeloma in Relapse

Start date: 2023-06-28
Primary completion: 2027-04-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.